← All diseases Infectious diseases

Chronic hepatitis C

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest quality evidence only (79)Meta-analysis (20)Treatment guideline (4)Phase 3 study (27)Randomized trial (14)Systematic review (14)Clinical trial (677)Review article (146)Early study (phase 1 or 2) (11)Case report (85)Laboratory or animal study (8)Commentary or editorial (53)Retracted publication (2) Studies currently recruiting participants only (15)

Filter

Publications and studies (1942)

• Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer. (2018/03/01) ♡
• Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosis. (2018/03/01) ♡
• Impact of Moderate Alcohol Discontinuation on Insulin Action and Secretion in Latinos With and Without Hepatitis C. (2018/03/01) ♡
• Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. Treatment of Chronic Hepatitis C Virus Infection in Children: A Position Paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. (2018/03/01) ♡
• Early and late changes in natural killer cells in response to ledipasvir/sofosbuvir treatment. (2018/03/01) ♡
• Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus-infected individuals. (2018/02/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. HCV load as a possible prognostic factor in patients with HCV-related DLBCL. (2018/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and efficacy of sofosbuvir-based treatment of acute hepatitis C in end-stage renal disease patients undergoing haemodialysis. (2018/02/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Efficacy of ribavirin against malignant glioma cell lines: Follow-up study. (2018/02/01) ♡
• Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success. (2018/02/01) ♡
• Influence of IL28B and MxA gene polymorphisms on HCV clearance in Han Chinese population. (2018/02/01) ♡
• Interleukin-7 augments CD8(+) T cells function and promotes viral clearance in chronic hepatitis C virus infection. (2018/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Impact of etiological treatment on prognosis. (2018/02/01) ♡
• Impact of circulating bacterial DNA in long-term glucose homeostasis in non-diabetic patients with HIV infection: cohort study. (2018/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review. (2018/01/28) ♡
• Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection. (2018/01/25) ♡
• Data Mining and Machine Learning Algorithms Using IL28B Genotype and Biochemical Markers Best Predicted Advanced Liver Fibrosis in Chronic Hepatitis C. (2018/01/23) ♡
• Is dietary glycemic load associated with liver fibrosis in hepatitis C? (2018/01/11) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Direct-acting agents for hepatitis C virus before and after liver transplantation. (2018/01/09) ♡
• Aeginetia indica Decoction Inhibits Hepatitis C Virus Life Cycle. (2018/01/09) ♡
• The Clinical Features of Patients with Chronic Hepatitis C Virus Infections Are Associated with Killer Cell Immunoglobulin-Like Receptor Genes and Their Expression on the Surface of Natural Killer Cells. (2018/01/05) ♡
• Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease. (2018/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Efficacy and safety of direct-acting antiviral agents when combined with secukinumab. (2018/01/01) ♡
• Effect of branched-chain amino acid supplementation on insulin resistance and quality of life in chronic hepatitis C patients. (2018/01/01) ♡
• Modeling the fiscal costs and benefits of alternative treatment strategies in the United Kingdom for chronic hepatitis C. (2018/01/01) ♡
• Low Prevalence of Insulin Resistance Among Iranian Patients with Chronic Hepatitis C Virus Infection: A Case-Control Study. (2018/01/01) ♡
• The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: A population cohort-study. (2018/01/01) ♡
• Health-related quality of life on the clinical course of patients with chronic hepatitis C receiving daclatasvir/asunaprevir therapy: A prospective observational study comparing younger (<70) and elderly (≥70) patients. (2018/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Hindsight is 20/20 - the importance of knowing! Know your patients' HBV status. (2018/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. All Oral Interferon-free Direct-acting Antivirals as Combination Therapies to Cure Hepatitis C. (2018/01/01) ♡
• Brain magnetic resonance spectroscopy and cognitive impairment in chronic hepatitis C patients. (2018/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [MALT lymphoma accompanied by elevated serum IgM levels mimicking Waldenström's macroglobulinemia]. (2018/01/01) ♡
• [The detection of antibodies to HCV F protein with immune enzyme analysis using synthetic peptide.]. (2018/01/01) ♡
• TLR4 and TLR7 genetic polymorphism in patients with HIV/HCV-coinfection: prevalence and gender-related features. (2018/01/01) ♡
• Steatosis influences hepatocytes proliferative potential in chronic hepatitis C patients. (2018/01/01) ♡
• Prevalence of anti-HCV antibodies in the population of young women and general medicine patients. (2018/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study (2018-12-31) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant (2018-12-20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection (2018-12-20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1b (2018-12-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Hepatitis C Virus in Neutrophil Granulocyte Progenitor Cells (2018-12-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Hepatitis C Surveillance With Linkage to Care of Patients From Non-ID Departments in Jiangsu (2018-12-13) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence (2018-12-13) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of Some Drugs on Liver Fibrosis (2018-12-10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and Cirrhosis (2018-11-27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Physiology of Fatigue in Patients With Chronic Liver Disease (2018-11-23) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation (2018-11-21) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 4 or 5 HCV Infection (2018-11-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting (2018-11-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment Study (2018-11-19) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.